HEREDITARY ANGIOEDEMA
Clinical trials for HEREDITARY ANGIOEDEMA explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Silencing the swelling: new drug aims to stop HAE attacks
Disease control Recruiting nowThis study tests a new medicine called ADX-324 for people with hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. The drug uses a technology called siRNA to lower a protein involved in triggering attacks. About 90 adults with HAE type 1 or 2 wi…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
New hope for kids with rare swelling disorder: early access drug available
Disease control AVAILABLEThis program provides early access to an investigational drug called sebetralstat for children aged 2 to 11 with hereditary angioedema (HAE). HAE causes sudden, painful swelling attacks. The drug is taken at the time of an attack to help control symptoms. The program is for child…
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New registry aims to shed light on rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information about people with rare diseases like amyloidosis, sarcoidosis, and many others. Researchers will track participants' health, treatments, and outcomes over time to better understand these conditions. The goal is to imp…
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC